Black Spade Acquisition III Co has announced a significant amendment to its business combination agreement with Astrum Space Inc. This update, filed with the SEC on November 5, 2026, is crucial as it outlines plans for the merged entity to be listed on either The New York Stock Exchange or Nasdaq. This move not only marks a pivotal moment for Black Spade but also signals potential shifts in the communications services industry, particularly within the growing space sector.
Company Overview
Black Spade Acquisition III Co, identified by the ticker symbols BIII, BIII-UN, and BIII-WT, operates in the communications services sector (SIC: 4899). The company is incorporated in the Cayman Islands and is categorized as an emerging growth company. Recent filings include a Form 425 and multiple 8-K forms, with the latest being on November 5, 2026.
Details from the Filing
The filing reveals that Black Spade III, Astrum, and Astrum Singapore have entered into a first amendment to their business combination agreement. This amendment allows for the listing of the merged company on major stock exchanges, which is a strategic move aimed at enhancing the visibility and marketability of the new entity. The filing states, "the parties agreed to amend the Business Combination Agreement to provide for the listing of the Merger Surviving Company on either The New York Stock Exchange or The Nasdaq Stock Market LLC." This change is expected to facilitate a smoother transition and integration post-merger.
Impact of the Amendment
This amendment could have significant implications for various stakeholders, including shareholders of Black Spade III and Astrum. The potential for a major stock exchange listing may attract new investors and increase liquidity for the merged entity. Additionally, this move could impact competitors within the communications services sector, as it positions Black Spade III more favorably in the market.
What's Next?
The filing does not specify the next steps following this amendment. However, it is expected that further updates will be provided as the merger progresses and as regulatory approvals are sought. Shareholders and interested parties are encouraged to stay informed through future filings and communications from Black Spade Acquisition III Co.
Read Next
Arrow Electronics releases Q3 results, highlighting growth
SAB Biotherapeutics reports Q3 results, outlines future plans
Akebia Therapeutics Reports Q3 2026 Financial Results
Intensity Therapeutics reports Q3 results for 2026
First Majestic Silver Corp. Reports Q3 2026 Financial Results
Advanced Flower Capital Reports Strong Q3 2026 Results




